Previous Close | 74.10 |
Open | 74.20 |
Bid | 73.81 x 1100 |
Ask | 73.83 x 800 |
Day's Range | 73.78 - 74.30 |
52 Week Range | 48.35 - 74.39 |
Volume | |
Avg. Volume | 6,304,783 |
Market Cap | 108.573B |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | 62.06 |
EPS (TTM) | 1.19 |
Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 81.86 |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.